This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Ayvakit (avapritinib)
General Description:
Ayvakit (avapritinib) is an oral targeted therapy used for the treatment of advanced gastrointestinal stromal tumors (GIST) with a genetic mutation in exon 18. It works by inhibiting the activity of mutant KIT and PDGFRA proteins, which drive tumor growth, helping to slow disease progression and improve patient outcomes.
Ayvakit is administered orally as tablets, with dosage and treatment schedules tailored by a qualified healthcare professional based on patient condition and response.
Getting Ayvakit (avapritinib) in India
Ayvakit is approved by major international regulatory agencies, including the FDA (U.S.) and EMA (Europe). While it may not yet be commercially available in India, patients can access it legally through a Named Patient Program (NPP) under the guidance of a licensed physician.
MitoGENE assists Indian patients in obtaining Ayvakit safely, managing all regulatory approvals, import permits, and logistics to ensure a compliant and secure process.
Disease Indication:
• Intestinal Cancer / Advanced Gastrointestinal Stromal Tumor (GIST) with exon 18 mutation
Manufacturer:
Blueprint Medicines
Usage:
Oral Tablets
Medicine Approved By:
• Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
Available Dosage Form & Package:
• 25 mg tablets, 30 tablets per pack
• 50 mg tablets, 30 tablets per pack
• 100 mg tablets, 30 tablets per pack
• 200 mg tablets, 30 tablets per pack
• 300 mg tablets, 30 tablets per pack
Shipping:
Room Temperature Shipping
Ayvakit is shipped under controlled room temperature conditions (15–25°C) to maintain stability and effectiveness. Standard shipping procedures ensure the medication remains safe and uncompromised during transit.
How to Access Ayvakit (avapritinib) in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Ayvakit (avapritinib) is not yet approved or commercially available in India, MitoGENE can assist you in accessing it legally through the Named Patient Program (NPP). Here’s how the process works:
